|本期目录/Table of Contents|

[1]原芳,李向辉,张爱枝.小剂量红霉素长期口服对支气管扩张症患者感染稳定期链球菌耐药性和氧化应激蛋白的影响[J].医学研究与战创伤救治(原医学研究生学报),2016,18(05):511-514.[doi:10.3969/j.issn.1672-271X.2016.05.019]
　YUAN Fang,LI Xiang-hui,ZHANG Ai-zhi.The effect of long-term low-dose oral erythromycin on streptococcusresistance and oxidative stress proteins for patients with stable bronchiectasis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(05):511-514.[doi:10.3969/j.issn.1672-271X.2016.05.019]
点击复制

小剂量红霉素长期口服对支气管扩张症患者感染稳定期链球菌耐药性和氧化应激蛋白的影响()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第18卷
期数:
2016年05期
页码:
511-514
栏目:
出版日期:
2016-09-20

文章信息/Info

Title:
The effect of long-term low-dose oral erythromycin on streptococcusresistance and oxidative stress proteins for patients with stable bronchiectasis
作者:
原芳1; 李向辉2; 张爱枝1
1. 010050内蒙古呼和浩特，内蒙古医科大学附属医院重症医学科；2. 473009河南南阳，南阳市中心医院中医科
Author(s):
YUAN Fang1;  LI Xiang-hui2;  ZHANG Ai-zhi1
1.Intensive Care Unit, the Affiliated Hospital of Inner Mongolia Medical University，huhhot, Inner Mongolia 010050,China；2. Department of Traditional Chinese Medcine, The Centrol Hospital of Nanyang City, Nanyang, Henan 473009,China
关键词:
红霉素; 支气管扩张; 氧化应激
Keywords:
erythromycin;  bronchiectasis;  oxidative stress
分类号:
R181.3+5
DOI:
10.3969/j.issn.1672-271X.2016.05.019
文献标志码:
A
摘要:
目的 观察长期口服小剂量红霉素对支气管扩张症稳定期患者的临床疗效及其对链球菌耐药性、氧化应激蛋白的影响。方法 104例支气管扩张症稳定期患者随机分为两组，治疗组口服红霉素，对照组口服安慰剂。6个月后，比较两组患者的胸部CT影像评分、口咽部优势菌的耐药率、外周血单个核细胞（PBMC）中ROS量及血清SOD活性。结果 治疗后治疗组胸部CT影像各项目评分与治疗前及对照组相比得到显著改善，差异有统计学意义（P＜0.05）。治疗组链球菌对红霉素耐药率34.62%显著高于对照组9.62%；治疗组PBMC中的ROS倍增数显著低于对照组，同时其SOD值显著高于对照组，差异有统计学意义（P＜0.05）。结论 长期小剂量服用红霉素改善支气管扩张稳定期患者的胸部CT影像评分，降低氧化应激蛋白含量，改善血清ROS及SOD含量，有较好的临床疗效，但能在一定程度上提高病菌对大环内酯类药物的耐受性。
Abstract:
Objective To observe the clinical efficacy of patients with stable bronchiectasis infection and the effect on bacterial resistance and oxidative stress proteins. Methods 104 cases with stable bronchiectasis patients were randomly divided into two groups. The treatment group was treated with oral erythromycin and the control group was treated with placebo. After six months, the Chest CT imaging rates, resistance rates of oropharyngeal dominant bacteria, the amount of ROS and the activity of SOD in peripheral blood mononuclear cells (PBMC) of two groups were compared. Results After treatment, the chest CT images scores and other each item were improved significantly compared with that before treatment and the control group, and the difference was statistically significant (P<0.05); The resistance rate of streptococci resistant to erythromycin of the treatment group was 34.62%, which was significantly higher than the control group (9.62%); The amount of PBMC ROS in the treatment group was significantly lower, while its SOD was significantly higher than the control group, and the difference was statistically significant (P<0.05). Conclusion Patients with stable bronchiectasis infection by long-term low-dose oral erythromycin can improve chest CT imaging score, reduce oxidative stress protein content, and improve serum ROS and SOD content, which has good clinical efficacy, but it can improve the germs of macrolide resistance in some time.

参考文献/References:

[1]邵有和,陈昌枝,覃淑娟,等. 小剂量红霉素对慢性阻塞性肺疾病稳定期患者免疫功能的干预研究[J]. 中华肺部疾病杂志, 2015，8(4):431-435.
[2]Martínez-García M, Sánchez CP, Moreno RM.The double-edged sword of neutrophilic inflammation in bronchiectasis[J].Eur Respir J, 2015, 46(4): 898-900.
[3]郑大炜. 纤维支气管镜肺泡灌洗治疗支气管扩张合并感染的疗效[J]. 中国内镜杂志,2015, 21(5): 491-493.
[4]樊有, 姜静, 蒋德升, 等. 96株儿童肺炎链球菌耐药情况分析[J].东南国防医药，2011,13(4): 299-301.
[5]刘青,施毅,朱素华,等.肺炎链球菌生物膜形成厚度与青霉素最低抑菌浓度的关系[J].医学研究生学报,2014,27(7):690-693.
[6]周小果, 郑大伟, 韩玉辉. 依替米星联合支气管肺泡灌洗治疗老年支气管扩张患者感染的临床研究[J]. 中华医院感染学杂志,2015，25(16): 3714-3716.
[7]唐云兰,高俊,高峰.慢性阻塞性肺疾病合并支气管扩张186例回顾性分析[J]. 世界中西医结合杂, 2015, 10(8):1147-1149.
[8]Gupta AK, Lodha R, Kabra SK. Non cystic fibrosis bronchiectasis[J]. Indian J Pediatr, 2015, 82(10): 938-944.
[9]王天玥, 尚云晓, 张晗. 呼出气一氧化氮浓度测定在儿童支气管哮喘和咳嗽变异性哮喘中的诊断价值[J]. 中国当代儿科杂志, 2015，17(8): 800-805.
[10]Sugianto TD, Chan HK. Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives[J].Expert Opin Drug Deliv, 2016,13(1):7-22.
[11]Hodge G, Upham JW, Chang AB, et al. Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with Bronchiectasis[J]. PLoS One, 2015, 10(8): e0133695.
[12]姜交泰,朱大庆,李炽观. 雾化吸入布地奈德与异丙托澳按治疗慢性阻塞性肺病急性加重期例疗效分析[J].中国医药指南，2013, 8(11):138-139.
[13]王昊, 徐保平, 刘秀云. 儿童支气管扩张症172例临床研究[J]. 中国实用儿科杂志, 2014, 29(12):936-939.
[14]刘春英, 周建华. 小剂量罗红霉素联合不同药物治疗支气管扩张症的疗效观察[J]. 中国医学创新, 2015, 11(35): 127-129.
[15]彭慧刚,王子婵,金丽珍.儿童肺炎支原体肺炎临床特征及红霉素与阿奇霉素序贯疗法的疗效观察[J].中国现代医生, 2015, 52(34): 122-124.
[16]Attar SM, Alamoudi OS, Aldabbag AA. Prevalence and risk factors of asymptomatic bronchiectasis in patients with rheumatoid arthritis at a tertiary care center in Saudi Arabia[J].Ann Thorac Med, 2015,10(3):176-180.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-12-09